Table of Contents

Diagnosis and classification of the BCR-ABL1-negative myeloproliferative neoplasms.
Genetics of the myeloproliferative neoplasms.
Cytogenetic findings in classical MPNs.
Prognostic factors in classic myeloproliferative neoplasms.
Therapy of polycythemia vera and essential thrombocythemia.
Conventional and investigational therapy for primary myelofibrosis.
Hematopoietic cell transplantation for myelofibrosis.
JAK2 inhibitors for therapy of myeloproliferative neoplasms.
Blastic transformation of classic myeloproliferative neoplasms.
Eosinophilic disorders: differential diagnosis and management.
Pathogenesis, diagnosis, classification, and management of systemic mastocytosis.